全文获取类型
收费全文 | 1486篇 |
免费 | 197篇 |
国内免费 | 205篇 |
专业分类
化学 | 1307篇 |
晶体学 | 2篇 |
力学 | 12篇 |
综合类 | 13篇 |
数学 | 65篇 |
物理学 | 489篇 |
出版年
2024年 | 6篇 |
2023年 | 64篇 |
2022年 | 115篇 |
2021年 | 219篇 |
2020年 | 193篇 |
2019年 | 83篇 |
2018年 | 98篇 |
2017年 | 83篇 |
2016年 | 78篇 |
2015年 | 83篇 |
2014年 | 83篇 |
2013年 | 110篇 |
2012年 | 64篇 |
2011年 | 80篇 |
2010年 | 45篇 |
2009年 | 46篇 |
2008年 | 56篇 |
2007年 | 58篇 |
2006年 | 53篇 |
2005年 | 51篇 |
2004年 | 39篇 |
2003年 | 39篇 |
2002年 | 14篇 |
2001年 | 21篇 |
2000年 | 18篇 |
1999年 | 22篇 |
1998年 | 8篇 |
1997年 | 15篇 |
1996年 | 10篇 |
1995年 | 5篇 |
1994年 | 2篇 |
1993年 | 7篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1988年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
排序方式: 共有1888条查询结果,搜索用时 15 毫秒
101.
Ruibing An Xiaoyang Cheng Shixuan Wei Yuxuan Hu Yidan Sun Zheng Huang Prof. Hong-Yuan Chen Prof. Deju Ye 《Angewandte Chemie (Weinheim an der Bergstrasse, Germany)》2020,132(46):20817-20825
Stimuli-responsive smart photosensitizer (PS) nanoassemblies that allow enhanced delivery and controlled release of PSs are promising for imaging-guided photodynamic therapy (PDT) of tumors. However, the lack of high-sensitivity and spatial-resolution signals and fast washout of released PSs from tumor tissues have impeded PDT efficacy in vivo. Herein, we report tumor targeting, redox-responsive magnetic and fluorogenic PS nanoassemblies ( NP-RGD ) synthesized via self-assembly of a cRGD- and disulfide-containing fluorogenic and paramagnetic small molecule ( 1-RGD ) for fluorescence/magnetic resonance bimodal imaging-guided tumor PDT. NP-RGD show high r1 relaxivity but quenched fluorescence and PDT activity; disulfide reduction by glutathione (GSH) promotes efficient disassembly into a small-molecule probe ( 2-RGD ) and an organic PS (PPa-SH), which could further bind with intracellular albumin, allowing prolonged retention and cascade activation of fluorescence and PDT to ablate tumors. 相似文献
102.
Dr. Yongxin Li Pan Sun Luyang Zhao Prof. Xuehai Yan Prof. Dennis K. P. Ng Prof. Pui-Chi Lo 《Angewandte Chemie (Weinheim an der Bergstrasse, Germany)》2020,132(51):23428-23438
A facile approach to assemble catalase-like photosensitizing nanozymes with a self-oxygen-supplying ability was developed. The process involved Fe3+-driven self-assembly of fluorenylmethyloxycarbonyl (Fmoc)-protected amino acids. By adding a zinc(II) phthalocyanine-based photosensitizer (ZnPc) and the hypoxia-inducible factor 1 (HIF-1) inhibitor acriflavine (ACF) during the Fe3+-promoted self-assembly of Fmoc-protected cysteine (Fmoc-Cys), the nanovesicles Fmoc-Cys/Fe@Pc and Fmoc-Cys/Fe@Pc/ACF were prepared, which could be disassembled intracellularly. The released Fe3+ could catalyze the transformation of H2O2 enriched in cancer cells to oxygen efficiently, thereby ameliorating the hypoxic condition and promoting the photosensitizing activity of the released ZnPc. With an additional therapeutic component, Fmoc-Cys/Fe@Pc/ACF exhibited higher in vitro and in vivo photodynamic activities than Fmoc-Cys/Fe@Pc, demonstrating the synergistic effect of ZnPc and ACF. 相似文献
103.
Chaonan Mu Wei Wang Jie Wang Chu Gong Dongmei Zhang Prof. Dr. Xinxing Zhang 《Angewandte Chemie (Weinheim an der Bergstrasse, Germany)》2020,132(48):21699-21703
While Type I and Type II photosensitizers are often carefully tailored to achieve their respective advantages in treating different cancers, the identifications of the Type I and II mechanisms as such, the key reaction intermediates, and the consequent oxidation products of the substrates have never been easy. Using our unique home-built field-induced droplet ionization mass spectrometry (FIDI-MS) method that selectively samples molecules at the air–water interface, here we show the facile determination of both Type I and II mechanisms of a poster-child photosensitizer, temoporfin, without the addition of any probes. The unstable doublet radical resulting from the hydrogen abstraction by the triplet temoporfin through the Type I mechanism is captured, manifesting the in situ advantage of FIDI-MS. We anticipate that the method developed in this study can be widely utilized in the future designs of novel photosensitizers and the screening of their photosensitization mechanisms. 相似文献
104.
Photodynamic therapy (PDT) has been received broad attentions as a cancer treatment, and fullerenes are potential photosensitizer owing to their unique electronic structures. However, fullerenes show insolubility in water for the special structure, which will induce aggregation to hinder the production of reactive oxygen species (ROS). Furthermore, the size of fullerenes is not conducive to reach the tumors through the enhanced permeability and retention (EPR) effect. Herein, a polyhydroxy fullerene-loaded metal-organic framework is designed and prepared to address the mentioned problems encountering with fullerenes as photosensitizers. The nanocomposite PHF@ZIF-8, which is synthesized by a simple one-pot method, displays great biocompatibility and outstanding photodynamic performance under the 448 nm laser irradiation. This work provides strong evidence for PHF@ZIF-8 as a promising photosensitizer candidate. 相似文献
105.
活性氧响应型抗肿瘤前药研究进展 总被引:1,自引:0,他引:1
活性氧(ROS)在机体信号转导和代谢中起着至关重要的作用,而ROS水平的升高与多种病变(癌症和炎症等)息息相关,基于肿瘤组织高水平ROS开发的肿瘤特异杀伤性前药策略,在增强药效和药物选择性方面提供了一种新颖的方法.本综述介绍了目前用于构建抗肿瘤前药的ROS敏感键:芳基硼酸/酯、烷基硫/硒醚、硫缩酮、过氧草酸酯、氨基丙烯酸酯、噻唑烷酮和α-酮酰胺等,并且详叙了基于这些敏感键设计的前药在抗肿瘤方向上的应用,同时探讨了现有ROS响应型前药系统的研究进展和局限性,并对未来的研究方向进行了展望. 相似文献
106.
Greta Linden Prof. Dr. Olalla Vázquez 《Chemistry (Weinheim an der Bergstrasse, Germany)》2020,26(44):10014-10023
Photodynamic therapy (PDT) leads to cancer remission via the production of cytotoxic species under photosensitizer (PS) irradiation. However, concomitant damage and dark toxicity can both hinder its use. With this in mind, we have implemented a versatile peptide-based platform of bioorthogonally activatable BODIPY-tetrazine PSs. Confocal microscopy and phototoxicity studies demonstrated that the incorporation of the PS, as a bifunctional module, into a peptide enabled spatial and conditional control of singlet oxygen (1O2) generation. Comparing subcellular distribution, PS confined in the cytoplasmic membrane achieved the highest toxicities (IC50=0.096±0.003 μm ) after activation and without apparent dark toxicity. Our tunable approach will inspire novel probes towards smart PDT. 相似文献
107.
《中国化学快报》2020,31(12):3121-3126
Combination therapy such as photothermal therapy (PTT) enhanced chemotherapy is regarded as a promising strategy for cancer treatment. Herein, we developed redox-responsive polymeric vesicles based on the amphiphilic triblock copolymer PCL-ss-PEG-ss-PCL. To avoid the limited therapeutic effect of chemotherapeutic drugs caused by systemic exposures and drug resistance, the redox-sensitive polymeric vesicles were cargoed with two chemotherapeutics: doxorubicin (DOX) and paclitaxel (PTX). Besides, indocyanine green (ICG) was encapsulated, and cell-penetrating peptides and LHRH targeting molecule were modified on the surface of polymeric vesicles. The results indicated that the polymeric vesicles can load different kinds of drugs with high drug loading content, trigger drug release in responsive to the reductive environment, realize high cellular uptake via dual peptides and laser irradiation, and achieve higher cytotoxicity via chemo-photothermal combination therapy. Hence, the redox-responsive LHRH/TAT dual peptides-conjugated PTX/DOX/ICG co-loaded polymeric micelles exhibited great potential in tumor-targeting and chemo-photothermal therapy. 相似文献
108.
光热治疗是近年来兴起的一种治疗方法,具有靶向性强、适应性广的特点。在光热治疗中,通过光热剂对光的吸收将光能转化为热能,从而实现治疗作用,因而光热剂的光热转化性能直接决定了光热治疗的效果。光热剂的种类丰富,涵盖由无机到有机等组成和性能各异的多种材料。其中,聚吡咯具备良好的生物相容性、优异的光稳定性以及光热转化性能,在光热治疗领域受到广泛关注,是一种拥有巨大应用潜力的光热剂,然而其在光热治疗领域的发展趋势及前景却鲜有报道。本文综述了聚吡咯及其纳米复合材料的制备方法,详述了聚吡咯及其纳米复合材料在光热治疗领域中的应用情况,包括聚吡咯基纳米材料的自身性能和实际光热治疗的效果,指出以聚吡咯为基体或修饰材料来制备具有CT、磁共振、光声显影及光热治疗性能的聚吡咯基复合材料已成为发展趋势。在此基础上,本文还总结了聚吡咯基纳米复合材料在制备和应用中存在的问题,并分析了其在发展过程中遇到的挑战以及在生物医学应用中的前景。 相似文献
109.
Air pollutants are perhaps the largest cause of diseases and death in the world today. Increasing urbanization and industrialization have caused an increase in number of diverse forms and types of new pollutants, which are difficult to detect and characterize due to their stench behaviour and complex sources of production. Such pollutants have been called emerging pollutants (EPs) and their list is ever increasing. Therefore, the understanding of the method of analysis and health implication of (EPs) in air is critical to providing a more robust understanding of exposure routes, regulations and mitigation. EPs in air discussed in this study are not in any way exhaustive but limited to emerging VOCs (including acrylonitrile, 1−3-butadiene, chloroform, dichloromethane, ethylene oxides, formaldehyde, toluene, trichloroethylene, 1,4-Dioxane) and metals (arsenic, manganese, and vanadium), ultrafine particles, micro- and nano- plastics, engineered nanoparticles, diesel/black carbon and bioaerosols. Occurrence, detection and health implications of these EPs in air are still unfolding due to limited monitoring studies, lack of standard methodology and regulations. To address this knowledge gap, authors conducted an in-depth review of available information. Their spatial distribution, analytical methods and health implications are discussed including the novel coronavirus (COVID-19) as a potential EP in air. The study concluded with highlights of gaps in knowledge and suggestions to key areas for future research. This information is of general interest to environmental scientists and of specific interest to both health and sanitation workers and policymakers at private, government and international organizations. 相似文献
110.
M.A. Mujawar H. Gohel S.K. Bhardwaj S. Srinivasan N. Hickman A. Kaushik 《Materials Today Chemistry》2020
Biosensors are emerging as efficient (sensitive and selective) and affordable analytical diagnostic tools for early-stage disease detection, as required for personalized health wellness management. Low-level detection of a targeted disease biomarker (pM level) has emerged extremely useful to evaluate the progression of disease under therapy. Such collected bioinformatics and its multi-aspects-oriented analytics is in demand to explore the effectiveness of a prescribed treatment, optimize therapy, and correlate biomarker level with disease pathogenesis. Owing to nanotechnology-enabled advancements in sensing unit fabrication, device integration, interfacing, packaging, and sensing performance at point-of-care (POC) has rendered diagnostics according to the requirements of disease management and patient disease profile i.e. in a personalized manner. Efforts are continuously being made to promote the state of art biosensing technology as a next-generation non-invasive disease diagnostics methodology. Keeping this in view, this progressive opinion article describes personalized health care management related analytical tools which can provide access to better health for everyone, with overreaching aim to manage healthy tomorrow timely. Considering accomplishments and predictions, such affordable intelligent diagnostics tools are urgently required to manage COVID-19 pandemic, a life-threatening respiratory infectious disease, where a rapid, selective and sensitive detection of human beta severe acute respiratory system coronavirus (SARS-COoV-2) protein is the key factor. 相似文献